77 / 88
75
LISI 2015
2015 highlights
Flagship products
Joint reconstruction:
orthopedic reconstruction
implants and instruments
(hip, shoulder, knee).
Spine, extremities,
trauma and dental:
orthopedic implants and
instruments, trauma
and extremities, spine,
maxillofacial and dental.
Customers
Ace Surgical;
Alphatec Spine;
Biosense Webster;
C2F Implants;
LDR Medical;
Medacta;
Medicrea;
Newdeal Integra;
Signature Orthopaedics;
Smith & Nephew;
Spineart;
Spineway;
Stryker;
Tornier;
Zimmer-Biomet.
Competitors
Accelent;
Avalign;
Coors Tek;
Greatbach;
Marle;
Norwood;
Orchid/Sandvik;
Paragon,
Tecomet
.
The Lyon plant certified
in Brazil
The Neyron (Ain) site, near Lyon, which specializes
in the production of implants (extremities, spine,
maxillofacial, dental, etc.), has passed the various
tests in the regulatory audit conducted in 2015
by the Brazilian health authorities (ANVISA).
This certification should open new business
opportunities in the emerging markets.
M a r k e t i n g /
Ramp-up
of generic ranges
Initiated in 2014, the development of a generic LISI MEDICAL
supply has accelerated in 2015. The year was indeed marked
by the finalization of the generic project for full un-cemented
hip replacement, offered packaged and sterilized by gamma
rays or ethylene oxide. LISI MEDICAL can now offer a full
denture to the distributors or to the OEMs that wish to
supplement their range. These ready-to-use products are
delivered with the associated surgical instruments and
benefit from the necessary clinical experience.
The first serial production of knee prostheses have also
been delivered throughout the year, 2015, allowing the site
dedicated to reconstruction to expand its offering, which
until then was very concentrated on hips. Finally, a unit
dedicated to plastic implants (Poly-ethylene, PEEK) has
been made operational and strengthened in 2015, in order to
provide an overall response for the spine and the extremities.
The extension in Caen
scheduled in 2016
To meet the growing increase in demand for
reconstruction implants, the factory extension at
the LISI MEDICAL Orthopaedics factory in Caen
was approved in 2015. This extension, scheduled
over 3,500 m2, will include new hip and knee
Commercial development
at Caen and Escondido
The historically single-client Caen factory has
continued the rollout of its commercial portfolio
with new clients, managing to double its sales
revenue in 2015. The Escondido site, in the United
States, as for itself has been able to increase its
sales in new markets, such as spine and trauma,
which are very promising in the United States.
This site has also been able to supplement
its coatings lines intended to facilitate osseo-
integration of dental or spinal implants, through
the acquisition of a type II anodizing line.
product lines. Work will begin in 2016 in order
to accommodate new equipment in the first
months of 2017. This extension will also enable
the reorganization of the product lines, some
involving major series.
In brief
LISI MEDICAL Orthopaedics Caen